Where is the immunochemistry reagents, analysers and test kits market heading?
Visiongain’s new 160-page report provides revenue forecasts to 2026 for the global immunochemistry market, 11 leading submarkets and 9 leading national markets.
This report forecasts the size of the immunochemistry market in the US, Japan, EU5: (Germany, France, Italy, Spain, UK), China, India, and the Rest of the World.
Along with revenue prediction for the overall world market, you see forecasts to 2026 for these submarkets:
• Immunochemistry reagents and tests kits
• Immunochemistry analysers
The study also forecasts immunochemistry reagents and tests kits subsectors:
• Anaemia/Vitamin tests
• Disease specific tests
• Drugs of abuse/toxicology tests
• Therapeutic drug monitoring
• Endocrinology tests
• Rapid tests
Our report provides revenues to 2026 for the sub-segments of the immunochemistry analysers, which includes:
• Chemiluminescence analysers
• ELISA analysers
• Immunofluorescence analysers
• Radioimmunoassay analysers
Assessments of the leading companies in the immunochemistry market – you find activities, products, capabilities and outlooks:
• Roche
• Siemens
• Abbott
• Danaher
• Ortho Clinical Diagnostics
• bioMerieux
Analysis of what stimulates and restrains the industry and market – assessments of challenges and strengths
Get our report Immunochemistry Reagents, Analysers and Test Kits Market 2016-2026: Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests,Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Executive Summary
1.1 Sector Highlights
1.2 Why You Should Read this Report
1.3 How this Study Delivers Information
1.4 Main Questions Answered by Our Analysis
1.5 Who is This Report For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
2. Introduction
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Types of IVD Tests
2.2.1 Point of Care Tests
2.2.2 Clinical Chemistry
2.2.3 Haematology
2.2.4 Microbiology
2.2.5 Genetic Testing
2.2.6 Immunochemistry
2.3 The Immune System
2.3.1 What is an Antigen?
2.3.2 What is an Antibody?
2.3.3 Antigen-Antibody Interaction
2.3.4 Affinity and Avidity of Antigen-Antibody Interactions
2.4 Polyclonal and Monoclonal Antibodies
2.5 Regulation of IVD Products
2.5.1 Regulation of IVD Products in the US
2.5.2 Regulation of IVD in the EU
2.5.3 Regulation of Laboratory Developed Tests
3. The Global Immunochemistry Market, 2016-2026
3.1 The Global Immunochemistry Market, 2016-2026
3.2 Global Immunochemistry Market Forecast, 2015-2026
3.3. Global Immunochemistry Market Trends, 2015-2026
3.3.1 High Demand Due to Increase in Chronic Patient Population
3.3.2 Automation of Laboratory Systems
3.3.3 Shift towards Decentralisation
3.3.4 Industry Consolidation
3.3.5 Investments by Private Equity/Venture Capital
3.3.6 Increased Awareness through Globalisation
3.4 Immunochemistry Market Drivers and Restraints, 2015-2026
4. Global Immunochemistry Reagents and Test Kits Market, 2015-2026
4.1 Introduction to Immunochemistry Reagents and Test Kits
4.2 Global Immunochemistry Reagents and Test Kits Market by Segment, 2016
4.3 Global Immunochemistry Reagents and Test Kits Market Forecast by Segment, 2016-2026
4.4 Disease Specific Tests Market
4.4.1 Disease Specific Tests Market by Segment, 2016
4.4.2 Disease Specific Tests Market Forecast by Segment, 2015-2026
4.4.3 Disease Specific Tests Market: Drivers and Restraints, 2015-2026
4.4.4 Infectious Diseases
4.4.4.1 Prevalence of Infectious Diseases
4.4.4.2 Infectious Disease Tests Market Forecast 2015-2026
4.4.4.3 Infectious Disease Tests Market Trends, 2015-2026
4.4.5 Autoimmune Diseases
4.4.5.1 Autoimmune Disease Tests Market Forecast 2015-2026
4.4.5.2 Autoimmune Disease Tests Market Trends, 2015-2026
4.4.6 Cancer and Tumour Markers
4.4.6.1 What are Tumour Markers?
4.4.6.1.1 Common Tumour Markers
4.4.6.2 Tumour Marker Market Forecast 2015-2026
4.4.6.3 Tumour Marker Market Trends, 2015-2026
4.4.7 Cardiovascular Diseases and Cardiac Markers
4.4.7.1 Prevalence of Cardiovascular Diseases
4.4.7.2 Common Cardiac Markers
4.4.7.3 Cardiac Marker Market Forecast 2015-2026
4.4.7.4 Cardiac Marker Market Trends, 2015-2026
4.4.8 Allergic Blood Tests
4.4.8.1 Prevalence of Allergy
4.4.8.2 Allergic Blood Tests Market Forecast 2015-2026
4.4.8.3 Allergic Blood Tests Market Trends, 2015-2026
4.4.8.4 Leading Allergy Testing Auto-Analysers, 2016
4.4.8.5 Allergy Blood Testing Dominated by Phadia (Part of Thermo Fisher)
4.5 Rapid Tests
4.5.1 Rapid Tests Market, 2015
4.5.2 Rapid Tests Market Forecast 2015-2026
4.5.3 Rapid Tests Market Trends, 2015-2026
4.5.4 Rapid Tests Market: Drivers and Restraints, 2015-2026
4.6 Drugs of Abuse
4.6.1 Extent of Illicit Drug Use
4.6.2 Common Drugs of Abuse
4.6.3 Drugs of Abuse/Toxicology Tests Market Forecast, 2015-2026
4.6.4 Drugs of Abuse/Toxicology Tests Market Trends, 2015-2026
4.6.5 Drugs of Abuse Tests Market: Drivers and Restraints, 2015-2026
4.7 Endocrinology Tests Market, 2015
4.7.1 Endocrinology Tests Market Forecast by Segment, 2015-2026
4.7.2 Trends in the Endocrinology Tests Market, 2015-2026
4.7.3 Endocrinology Tests Market: Drivers and Restraints, 2015-2026
4.8 Therapeutic Drug Monitoring
4.8.1 Commonly Monitored Drugs
4.8.1.1 Antiepileptics
4.8.1.2 Antiarrhythmics
4.8.1.3 Antibiotics
4.8.1.4 Immunosuppressants
4.8.1.5 Bronchodilators
4.8.1.6 Antimanics
4.8.2 Therapeutic Drug Monitoring Market, 2015
4.8.3 Immunoassays Preferred Over Chromatographic Methods for TDM
4.8.4 Therapeutic Drug Monitoring Market Forecast 2015-2026
4.8.5 Therapeutic Drug Monitoring Market Trends, 2015-2026
4.8.6 Therapeutic Drug Monitoring Market: Drivers and Restraints, 2015-2026
4.9 Anaemia/Vitamin Tests Market, 2015
4.9.1 What is Anaemia?
4.9.2 Types of Anaemia
4.9.2.1 Iron Deficiency Anaemia (IDA)
4.9.2.2 Vitamin Deficiency in Anaemia
4.9.3 Diagnosis of Vitamin B12 Deficiency and Folic Acid Deficiency
4.9.4 Vitamin D Deficiency Affects a Large Population Worldwide
4.9.5 Diagnosis of Vitamin D Deficiency
4.9.5.1 Immunoassays for Vitamin D Measurement
4.9.6 Anaemia/ Vitamin Tests Market Forecast 2015-2026
4.9.7 Anaemia/Vitamin Tests Market Trends, 2015-2026
4.9.8 Regulatory Approvals
4.9.9 Anaemia/Vitamin Tests Market: Drivers and Restraints, 2015-2026
5. Global Immunochemistry Analysers Market, 2015-2026
5.1 Introduction to Immunochemistry Analysers
5.1.1 Radioimmunoassay Analysers
5.1.2 Enzyme Immunoassay Analysers
5.1.3 Immunofluorescence Analysers
5.1.4 Chemiluminescence Analysers
5.2 Immunochemistry Analysers Market, 2015
5.3 Immunochemistry Analysers Market Forecast by Segment, 2015-2026
5.4 Immunochemistry Analysers Market Trends, 2015-2026
6. Leading National Immunochemistry Markets, 2016-2026
6.1 Regional Breakdown of the Global Immunochemistry Market, 2015
6.2 Global Immunochemistry Market: Regional Forecast, 2015-2026
6.3 The US Market
6.3.1 The US Market: Growth Drivers
6.3.1.1 Increasing Prevalence of Chronic Diseases
6.3.1.2 Strong Growth in the Drugs of Abuse Market
6.3.2 The US Market: Growth Restraints
6.3.2.1 Medical Device Excise Tax
6.4 The European Market
6.4.1 Germany and France
6.4.2 The Italian Market
6.4.3 The Spanish Market
6.4.4 The UK Market
6.5 The Japanese Market
6.6 The Chinese Market
7. Leading Companies in the Immunochemistry Market, 2015
7.1 Roche
7.1.1 Sales and Performance Analysis, 2015
7.1.2 Roche Diagnostics
7.1.3 Investment in Research and Development
7.1.4 Historical Product Launches in the Immunochemistry Market
7.1.5 Construction of New Diagnostic Production Facility
7.1.6 Roche: Immunochemistry Analysers
7.1.6.1 Cobas 8000 Analyser
7.1.6.2 Cobas 6000 Analyser
7.1.6.3 Cobas 4000 Analyser
7.2 Siemens
7.2.1 Sales and Performance Analysis, 2015
7.2.2 Siemens Healthcare Sector, 2015
7.2.3 Siemens: R&D Expenses, 2015
7.2.4 Siemens: Immunochemistry Analysers
7.2.4.1 Dimension Vista Systems
7.2.4.2 Advia Centaur XP Immunoassay System
7.2.4.3 Advia Centaur CP Immunoassay System
7.2.4.4 Immulite Series
7.2.4.4.1 Immulite 2000 Immunoassay System
7.2.4.4.2 Immulite 1000 Immunoassay System
7.3 Abbott Laboratories (Now Abbott and AbbVie)
7.3.1 Sales and Performance Analysis, 2015
7.3.2 Abbott: Immunochemistry Analysers
7.3.2.1 Abbott Prism
7.3.2.2 Architect ci8200
7.3.2.3 Architect ci16200
7.3.2.4 Architect ci4100
7.4 Danaher
7.4.1 Sales and Performance Analysis, 2015
7.4.2 Life Sciences & Diagnostics
7.4.3 Danaher: Immunochemistry Analysers
7.5 Ortho Clinical Diagnostics (formerly part of Johnson & Johnson)
7.5.1 Sales and Performance Analysis, 2015
7.5.2 Ortho Clinical Diagnostics: Immunodiagnostic Analysers
7.6 bioMérieux
7.6.1 Sales and Performance Analysis, 2015
7.6.2 Breakdown of Sales by Technology, 2015
7.6.3 bioMérieux: Recent Collaborations
7.6.3.1 Collaboration with Royal Philips Electronics
7.6.3.2 Collaboration with Hospices Civils De Lyon
8. SWOT Analysis of the Immunochemistry Market, 2016-2026
8.1 Strengths
8.1.1 Patient Demographics
8.1.2 Automation and Other Technological Advancements
8.1.3 IVD Tests are Vital for Disease Management
8.1.4 Mature Market
8.2 Weaknesses
8.2.1 Regulatory Board Approval
8.2.2 Reimbursement Issues
8.3 Opportunities
8.3.1 Globalisation
8.4 Threats
8.4.1 Medical Device Excise Tax
8.4.2 Regulatory Issues – Lack of Clarity Can be Costly
9. Conclusions
9.1 The Immunochemistry Market - Driven by the Reagents and Test Kits Market
9.2 Rapid Tests Will Remain the Fastest Growing Segment
9.3 The US was the Leading National Market in 2015
9.4 Future Outlook and Concluding Remarks
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Table
Table 1.1 (Sample) Global Immunochemistry Market Forecast ($bn), (%), 2015-2026
Table 3.1 Immunochemistry Market: Revenue ($bn) and Market Shares (%) by Segment, 2016
Table 3.2 Global Immunochemistry Market Forecast ($bn), AGR (%), CAGR (%), 2015-2026
Table 3.3 Key Mergers & Acquisition Deals, 2011-2016
Table 3.4 Immunochemistry Market: Drivers and Restraints, 2015-2026
Table 4.1 Global Immunochemistry Reagents and Test Kits Market: Revenue ($bn) and Market Shares (%) by Segment, 2016
Table 4.2 Global Immunochemistry Reagents and Test Kits Market Forecast by Segment ($bn), AGR(%), CAGR(%), 2015-2026
Table 4.3 Disease Specific Tests Market: Revenue ($bn) and Market Shares (%) by Segment, 2016
Table 4.4 Disease Specific Tests Market Forecast by Segment ($bn), AGR(%), CAGR(%), 2015-2026
Table 4.5 Disease Specific Tests Market: Drivers and Restraints, 2015-2026
Table 4.6 Common Tumour Markers Used in Diagnosis, 2016
Table 4.7 Common Cardiac Markers Used in Diagnosis, 2016
Table 4.8 Leading Allergy Testing Auto Analysers, 2016
Table 4.9 Rapid Tests Market: Drivers and Restraints, 2015-2026
Table 4.10 Common Drugs of Abuse, 2016
Table 4.10.1 (Contd) Common Drugs of Abuse, 2016
Table 4.11 Drugs of Abuse Market: Drivers and Restraints, 2015-2026
Table 4.12 Commonly Monitored Endocrine Hormones
Table 4.13 Endocrinology Tests: Revenue ($m) and Market Shares (%) by Segment, 2015
Table 4.14 Endocrinology Tests Market Forecast by Segment ($m), AGR(%), CAGR(%), 2015-2026
Table 4.15 Endocrinology Tests Market: Drivers and Restraints, 2015-2026
Table 4.16 Therapeutic Drug Monitoring Market: Drivers and Restraints, 2015-2026
Table 4.17 Anaemia/Vitamin Tests Market: Drivers and Restraints, 2015-2026
Table 5.1 Immunochemistry Analysers Market: Revenue ($bn) and Market Shares (%) by Segment, 2015
Table 5.2 Immunochemistry Analysers Market Forecast ($bn), AGR (%) and CAGR (%) by Segment, 2015-2026
Table 6.1 Leading National Immunochemistry Markets: Revenue ($bn) and Market Shares (%), 2015
Table 6.2 Global Immunochemistry Market Forecast ($bn), AGR(%) and CAGR (%) by Leading National Markets, 2015-2026
Table 6.3 The Leading European Immunochemistry National Markets: Revenue ($bn) and Market Shares (%), 2015
Table 6.4 The European Immunochemistry Market Forecast ($bn), AGR (%) and CAGR (%) by leading Countries, 2015-2026
Table 7.1 Roche: Net sales ($bn) and Net Sales Shares (%) by Sector, 2015
Table 7.2 Roche Diagnostics: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
Table 7.3 Roche: Historic Product Launches in the Immunochemistry Market,
Table 7.4 Siemens: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
Table 7.5 Siemens Healthcare: Net Sales ($bn) by Sector, 2015
Table 7.6 Siemens: R&D Expenses ($bn), 2014 & 2015
Table 7.7 Abbott: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
Table 7.8 Danaher: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
Table 7.9 Danaher: Immunochemistry Analysers
Table 7.10 Johnson & Johnson Net sales ($bn) and Net Sales Shares (%) by Segment, 2015
Table 7.11 Ortho Clinical Diagnostics: Immunodiagnostic Analysers
Table 7.12 bioMérieux: Net Sales ($bn) and Net Sales Shares (%) by Sector, 2015
Table 7.13 bioMérieux: Net Sales ($bn) and Net Sales Shares (%) by Technology, 2015
Table 8.1 SWOT Analysis of the Immunochemistry Market, 2016
Table 9.1 Immunochemistry Market Forecast ($bn, %) by Segments, 2015, 2020, 2026
List of Figures
Figure 3.1 Immunochemistry Market: Revenue ($bn) by Segment, 2016
Figure 3.2 Immunochemistry Market: Market Shares (%) by Segment, 2016
Figure 3.3 Global Immunochemistry Market Forecast ($bn), 2015-2026
Figure 4.1 Global Immunochemistry Reagents and Test Kits Market: Revenue ($bn) by Segment, 2016
Figure 4.2 Global Immunochemistry Reagents and Test Kits Market: Market Shares (%) by Segment, 2016
Figure 4.3 Disease Specific Tests Market: Revenue ($bn) by Segment, 2016
Figure 4.4 Disease Specific Tests Market: Market Shares (%) by Segment, 2016
Figure 4.5 Infectious Disease Tests Market Forecast ($bn), 2015-2026
Figure 4.6 Autoimmune Disease Tests Market Forecast ($bn), 2015-2026
Figure 4.7 Tumour Marker Market Forecast ($bn), 2015-2026
Figure 4.8 Cardiac Marker Market Forecast ($bn), 2015-2026
Figure 4.9 Allergic Blood Tests Market Forecast ($bn), 2015-2026
Figure 4.10 Rapid Tests Market Forecast ($bn), 2015-2026
Figure 4.11 Drugs of Abuse/Toxicology Market Forecast ($bn), AGR (%), 2015-2026
Figure 4.12 Endocrinology Tests Market Shares (%) by Segment, 2015
Figure 4.13 Endocrinology Tests Market Forecast ($m), 2015-2026
Figure 4.14 Thyroid and Fertility Tests Market Forecast ($m), 2015-2026
Figure 4.15 Therapeutic Drug Monitoring Market Forecast ($bn), 2015-2026
Figure 4.16 Anaemia/Vitamin Tests Market Forecast ($bn), 2015-2026
Figure 5.1 Immunochemistry Analysers Market: Revenue ($bn) by Segment, 2015
Figure 5.2 Chemiluminescence Analysers Market Forecast ($bn), 2015-2026
Figure 5.3 Immunochemistry Analysers Market Forecast ($bn) by Segment, 2015-2026
Figure 6.1 Immunochemistry Market: Revenue ($bn) in Leading National Markets, 2015
Figure 6.2 Immunochemistry Market: Market Shares (%) in Leading National Markets, 2015
Figure 6.3 US Immunochemistry Market Forecast ($bn), 2015-2026
Figure 6.4 US Survey of Illicit Drug Use Among People Aged 12 or Older: Numbers (Million), One Month in 2011
Figure 6.5 The Leading European Immunochemistry National Markets: Revenue ($bn), 2015
Figure 6.6 The Leading European Immunochemistry National Markets: European Market Shares (%), 2015
Figure 6.7 The European Immunochemistry Market Forecast ($bn), 2015-2026
Figure 6.8 Immunochemistry Market Forecast ($bn), in Germany, 2015-2026
Figure 6.9 Immunochemistry Market Forecast ($bn), in France, 2015-2026
Figure 6.10 The Italian Immunochemistry Market Forecast ($bn), 2015-2026
Figure 6.11 The Spanish Immunochemistry Market Forecast ($bn), 2015-2026
Figure 6.12 UK Immunochemistry Market Forecast ($bn), 2015-2026
Figure 6.13 Japanese Immunochemistry Market Forecast ($bn), 2015-2026
Figure 6.14 Chinese Immunochemistry Market Forecast ($bn), 2015-2026
Figure 6.15 Indian Immunochemistry Market Forecast ($bn), 2015-2026
Figure 7.1 Roche: Net Sales ($bn) by Sector, 2015
Figure 7.2 Roche: Net Sales Shares (%) by Sector, 2015
Figure 7.3 Roche Diagnostics: Net Sales ($bn) by Sector, 2015
Figure 7.4 Siemens: Net Sales ($bn) by Sector, 2015
Figure 7.5 Siemens: Net Sales Shares (%) by Sector, 2015
Figure 7.6 Siemens: R&D Expenses ($bn), 2014 & 2015
Figure 7.7 Abbott: Net Sales ($bn) by Sector, 2015
Figure 7.8 Abbott: Net Sales Shares (%) by Sector, 2015
Figure 7.10 Danaher: Net Sales ($bn) by Sector, 2015
Figure 7.11 Danaher: Net Sales Shares (%) by Sector, 2015
Figure 7.12 Johnson & Johnson: Net Sales ($bn) by Segment, 2015
Figure 7.13 Johnson & Johnson: Net Sales Shares (%) by Segment, 2015
Figure 7.14 bioMérieux: Net Sales ($bn) by Sector, 2015
Figure 7.15 bioMérieux: Net Sales Shares (%) by Sector, 2015
Figure 7.16 bioMérieux: Net Sales ($bn) by Technology, 2015
Figure 7.17 bioMérieux: Net Sales Shares (%) by Technology, 2015
Figure 8.1 Countries with Highest Share of 60+ Population, 2016
Figure 9.1 Global Immunochemistry Market Forecast ($bn), 2015, 2020, 2026
Figure 9.2 Rapid Tests Market Forecast ($bn), 2015, 2020, 2026
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
